Related Experiment Video
Updated: Nov 24, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Botulinum toxin A as monotherapy for syringoma
José Luis Zaldivar-Fujigaki1, Lucia Achell Nava1,2
1Departmente of Dermatology, National Medical Center 20 de Noviembre ISSSTE, Mexico City, Mexico.
Botulinum toxin A offers a new, effective treatment for syringoma, a common skin condition. This study shows significant improvement in patients after intradermal injections, presenting a safe therapeutic option.
Area of Science:
- Dermatology
- Oncology
Background:
- Syringoma is a benign skin tumor arising from eccrine sweat ducts.
- Existing treatments for syringoma are often unsuccessful, leading to patient dissatisfaction.
More Related Videos
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...